The estimated Net Worth of Randall E Woods is at least $638 Thousand dollars as of 12 November 2019. Mr. Woods owns over 3,046 units of Sophiris Bio Inc stock worth over $0 and over the last 17 years he sold SPHS stock worth over $0. In addition, he makes $637,543 as President, Chief Executive Officer, and Director at Sophiris Bio Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Woods SPHS stock SEC Form 4 insiders trading
Randall has made over 8 trades of the Sophiris Bio Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 3,046 units of SPHS stock worth $98,995 on 12 November 2019.
The largest trade he's ever made was exercising 76,268 units of Sophiris Bio Inc stock on 30 March 2015 worth over $106,013. On average, Randall trades about 3,560 units every 76 days since 2008. As of 12 November 2019 he still owns at least 17,276 units of Sophiris Bio Inc stock.
You can see the complete history of Mr. Woods stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Randall Woods biography
Randall E. Woods serves as President, Chief Executive Officer, Director of Sophiris Bio Inc. Prior to joining Sophiris, Mr. Woods was serving as a consultant to a number of private biotechnology companies. From September 2007 until September 2011, Mr. Woods was President and Chief Executive Officer of Sequel Pharmaceuticals, a private biotechnology company. Mr. Woods was the President and Chief Executive Officer of NovaCardia, Inc., a pharmaceutical company focused on cardiovascular diseases, until its acquisition by Merck & Co. From May 1996 until July 2003 and prior to NovaCardia, Mr. Woods was President and Chief Executive Officer of Corvas International, Inc., a publicly held biopharmaceutical company focused on cardiovascular disease and cancer, until its acquisition by Dendreon Corporation in July 2003. Before joining Corvas, he served as President of Boehringer Mannheim’s U.S. pharmaceutical operations from March 1994 until March 1996 and was Vice President of Marketing and Sales at Boehringer Mannheim from December 1993 to February 1994. Prior to that he spent 20 years at Eli Lilly & Company in various sales and marketing positions from 1973 to December 1993. Mr. Woods is a past Chairman for the advisory board of UC San Diego’s Sulpizio Family Cardiovascular Center and is a past Chairman of the Board of Directors for BIOCOM, a life science industry association in Southern California. Mr. Woods serves on the Board of Directors of Arena Pharmaceuticals. He received his B.S. in biology and chemistry from Ball State University and an M.B.A. in marketing from Western Michigan University. Based on Mr. Woods’ expertise and extensive experience in biotechnology and service as our Chief Executive Officer and President, the Board believes Mr. Woods has the appropriate set of skills to serve on our Board.
What is the salary of Randall Woods?
As the President, Chief Executive Officer, and Director of Sophiris Bio Inc, the total compensation of Randall Woods at Sophiris Bio Inc is $637,543. There are no executives at Sophiris Bio Inc getting paid more.
How old is Randall Woods?
Randall Woods is 67, he's been the President, Chief Executive Officer, and Director of Sophiris Bio Inc since 2012. There are 3 older and 4 younger executives at Sophiris Bio Inc. The oldest executive at Sophiris Bio Inc is Lars Ekman, 70, who is the Chairman of the Board.
What's Randall Woods's mailing address?
Randall's mailing address filed with the SEC is 1258 PROSPECT STREET, , LA JOLLA, CA, 92037.
Insiders trading at Sophiris Bio Inc
Over the last 11 years, insiders at Sophiris Bio Inc have traded over $592,052 worth of Sophiris Bio Inc stock and bought 1,642,180 units worth $8,144,540 . The most active insiders traders include Capital, Llc Boxer Asset Ma..., Capital, Llc Boxer Asset Ma..., and William R Rohn. On average, Sophiris Bio Inc executives and independent directors trade stock every 155 days with the average trade being worth of $0. The most recent stock trade was executed by Randall E Woods on 19 September 2018, trading 10,000 units of SPHS stock currently worth $26,300.
What does Sophiris Bio Inc's logo look like?
Complete history of Mr. Woods stock trades at Arena Pharmaceuticals Inc and Sophiris Bio Inc
Sophiris Bio Inc executives and stock owners
Sophiris Bio Inc executives and other stock owners filed with the SEC include:
-
Randall Woods,
President, Chief Executive Officer, Director -
Allison Hulme,
Director -
Randall E. Woods,
Pres, CEO & Director -
Peter Slover,
Chief Financial Officer -
Lars Ekman,
Chairman of the Board -
Gerald Proehl,
Independent Director -
John Geltosky,
Independent Director -
Iain R. Mant Esq.,
Corp. Sec. -
Dr. James Joseph Beesley,
Sr. Director of Investor Relations -
Dr. Samuel R. Denmeade M.D.,
Chief Scientific Officer & Member of the Scientific Advisory Board -
James L Heppell,
Director -
Joseph L Turner,
Director -
Capital, Llc Boxer Asset Ma...,
-
William R Rohn,
Director -
Capital, Llc Boxer Asset Ma...,